Atlas Trials

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19

Clinical trial NCT06039163 · COMPLETED

Trial details

NCT number
NCT06039163
Sponsor
Huahui Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2022-04-16
Primary completion
2022-10-10
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.